Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.39 USD | -1.04% | +1.84% | -30.24% |
04-20 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
04-20 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.24% | 4.27B | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Wolfe Research Starts Immunovant With Outperform Rating, $55 Price Target